Fibroblasts as immune regulators in infection, inflammation and cancer.

Duvall, M. Atlas d’Embryologie (Masson, France, 1879).

Tarin, D. & Croft, C. Ultrastructural features of wound healing in mouse skin. J. Anat. 105, 189–190 (1969).

pubmed: 5803198

Pierer, M. et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J. Immunol. 172, 1256–1265 (2004).

pubmed: 14707104 doi: 10.4049/jimmunol.172.2.1256

Bombardieri, M. et al. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 70, 1857–1865 (2011).

pubmed: 21798884 doi: 10.1136/ard.2011.150219

Brentano, F., Schorr, O., Gay, R. E., Gay, S. & Kyburz, D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum. 52, 2656–2665 (2005).

pubmed: 16142732 doi: 10.1002/art.21273

Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322–335 (2008).

pubmed: 18506843 doi: 10.1002/hep.22306

Henderson, N. C., Rieder, F. & Wynn, T. A. Fibrosis: from mechanisms to medicines. Nature 587, 555–566 (2020). A recent review of the mechanisms regulating fibrosis including a comprehensive view of the role of fibroblasts, their heterogeneity and their tissue interactions.

pubmed: 33239795 doi: 10.1038/s41586-020-2938-9 pmcid: 8034822

Castor, C. W., Prince, R. K. & Dorstewitz, E. L. Characteristics of human “fibroblasts” cultivated in vitro from different anatomical sites. Lab. Invest. 11, 703–713 (1962).

pubmed: 13877250

Chang, H. Y. et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA 99, 12877–12882 (2002). The first article to uncover positional memory in cultured skin fibroblasts. Fibroblasts isolated from different anatomical locations display transcriptional differences that are maintained across passages and this implicates a role for HOX genes in this process.

pubmed: 12297622 pmcid: 130553 doi: 10.1073/pnas.162488599

Rinn, J. L., Bondre, C., Gladstone, H. B., Brown, P. O. & Chang, H. Y. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLoS Genet. 2, e119 (2006).

pubmed: 16895450 pmcid: 1523235 doi: 10.1371/journal.pgen.0020119

Frank-Bertoncelj, M. et al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat. Commun. 8, 14852 (2017).

pubmed: 28332497 pmcid: 5376654 doi: 10.1038/ncomms14852

Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714–730.e22 (2019). A large scRNA-seq atlas of ulcerative colitis including inflamed and adjacent non-inflamed intestinal biopsy samples alongside healthy control samples consisting of 366,650 cells.

pubmed: 31348891 pmcid: 6662628 doi: 10.1016/j.cell.2019.06.029

Culemann, S. et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature 572, 670–675 (2019).

pubmed: 31391580 pmcid: 6805223 doi: 10.1038/s41586-019-1471-1

Krausgruber, T. et al. Structural cells are key regulators of organ-specific immune responses. Nature 583, 296–302 (2020). A landmark article in which the transcriptome and epigenome of epithelial cells, endothelial cells and fibroblasts residing in different organs were profiled. This revealed imprinted immune programmes unique to the surrounding tissue that are activated upon viral infection.

pubmed: 32612232 pmcid: 7610345 doi: 10.1038/s41586-020-2424-4

Huang, Y. et al. Single cell transcriptomic analysis of human mesenchymal stem cells reveals limited heterogeneity. Cell Death Dis. 10, 1–12 (2019).

doi: 10.1038/s41419-019-1583-4

Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 175, 372–386.e17 (2018). The first study to sequence the intestinal stroma affected by ulcerative colitis at the single-cell level. This revealed unique fibroblast subsets whose transcriptome implicates unique functions. In particular, this article highlights expansion of a potential pathogenic population.

pubmed: 30270042 pmcid: 6176871 doi: 10.1016/j.cell.2018.08.067

Zepp, J. A. et al. Distinct mesenchymal lineages and niches promote epithelial self-renewal and myofibrogenesis in the lung. Cell 170, 1134–1148.e10 (2017).

pubmed: 28886382 pmcid: 5718193 doi: 10.1016/j.cell.2017.07.034

Janson, D. G., Saintigny, G., van Adrichem, A., Mahé, C. & el Ghalbzouri, A. Different gene expression patterns in human papillary and reticular fibroblasts. J. Invest. Dermatol. 132, 2565–2572 (2012).

pubmed: 22696053 doi: 10.1038/jid.2012.192

Lee, D. Y. & Cho, K. H. The effects of epidermal keratinocytes and dermal fibroblasts on the formation of cutaneous basement membrane in three-dimensional culture systems. Arch. Dermatol. Res. 296, 296–302 (2005).

pubmed: 15650892 doi: 10.1007/s00403-004-0529-5

Sorrell, J. M., Baber, M. A. & Caplan, A. I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J. Cell. Physiol. 200, 134–145 (2004).

pubmed: 15137066 doi: 10.1002/jcp.10474

Dobie, R. et al. Single-cell transcriptomics uncovers zonation of function in the mesenchyme during liver fibrosis. Cell Rep. 29, 1832–1847.e8 (2019).

pubmed: 31722201 pmcid: 6856722 doi: 10.1016/j.celrep.2019.10.024

Öhlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 214, 579–596 (2017). One of the first articles to identify functionally distinct fibroblasts in cancer. Here, IL-6- and αSMA- expressing fibroblast subsets observed in pancreatic cancer could be replicated in an in vitro culture system. Examination of these cultures suggested distinct roles in immune crosstalk and matrix desmoplasia, respectively, leading to the terms ‘iCAFs’ and ‘myCAFs’.

pubmed: 28232471 pmcid: 5339682 doi: 10.1084/jem.20162024

Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392–401 (2006).

pubmed: 16572188 doi: 10.1038/nrc1877

Monteran, L. & Erez, N. The dark side of fibroblasts: cancer-associated fibroblasts as mediators of immunosuppression in the tumor microenvironment. Front. Immunol. 10, 1835 (2019).

pubmed: 31428105 pmcid: 6688105 doi: 10.3389/fimmu.2019.01835

Bartoschek, M. et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat. Commun. 9, 5150 (2018).

pubmed: 30514914 pmcid: 6279758 doi: 10.1038/s41467-018-07582-3

Costa, A. et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell 33, 463–479.e10 (2018).

pubmed: 29455927 doi: 10.1016/j.ccell.2018.01.011

Davidson, S. et al. Single-cell RNA sequencing reveals a dynamic stromal niche that supports tumor growth. Cell Rep. 31, 107628 (2020).

pubmed: 32433953 pmcid: 7242909 doi: 10.1016/j.celrep.2020.107628

Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102–1123 (2019).

pubmed: 31197017 pmcid: 6727976 doi: 10.1158/2159-8290.CD-19-0094

Lambrechts, D. et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289 (2018).

pubmed: 29988129 doi: 10.1038/s41591-018-0096-5

Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).

pubmed: 24925914 pmcid: 4123637 doi: 10.1126/science.1254257

Puram, S. V. et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171, 1611–1624.e24 (2017).

pubmed: 29198524 pmcid: 5878932 doi: 10.1016/j.cell.2017.10.044

Su, S. et al. CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell 172, 841–856.e16 (2018).

pubmed: 29395328 doi: 10.1016/j.cell.2018.01.009

Brechbuhl, H. M. et al. Fibroblast subtypes regulate responsiveness of luminal breast cancer to estrogen. Clin. Cancer Res. 23, 1710–1721 (2017).

pubmed: 27702820 doi: 10.1158/1078-0432.CCR-15-2851

Kieffer, Y. et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 10, 1330–1351 (2020).

pubmed: 32434947 doi: 10.1158/2159-8290.CD-19-1384

Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019). An article showing that pathogenic functions of fibroblasts in RA differ according to their location in the lining layer and the sublining layer. Here, THY1

pubmed: 31142839 pmcid: 6690841 doi: 10.1038/s41586-019-1263-7

Wei, K. et al. Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259–264 (2020). An article identifying the importance of local tissue cues to maintain fibroblast subset identity in RA. The endothelium is critical for the maintenance and expansion of the sublining-layer population.

pubmed: 32499639 pmcid: 7841716 doi: 10.1038/s41586-020-2222-z

Nygaard, G. & Firestein, G. S. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat. Rev. Rheumatol. 16, 316–333 (2020). A recent review of the role of fibroblasts in RA.

pubmed: 32393826 pmcid: 7987137 doi: 10.1038/s41584-020-0413-5

Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 20, 928–942 (2019). An article demonstrating that the composition of functionally distinct lining-layer and sublining-layer fibroblasts depends on the disease context. Inflammatory sublining-layer fibroblasts are enriched in leukocyte-rich RA, whereas lining-layer fibroblasts are enriched in leukocyte-poor RA and osteoarthritis.

pubmed: 31061532 pmcid: 6602051 doi: 10.1038/s41590-019-0378-1

Biffi, G. et al. IL1-induced Jak/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 9, 282–301 (2019). A key article highlighting the plasticity between iCAF and myCAF populations. A positive-feedback loop via NF-κB, LIF and the JAK–STAT pathway propagates the iCAF phenotype. However, perturbation of this feedback loop by TGFβ induces a myCAF phenotype.

pubmed: 30366930 doi: 10.1158/2159-8290.CD-18-0710

Crowley, T. et al. Priming in response to pro-inflammatory cytokines is a feature of adult synovial but not dermal fibroblasts. Arthritis Res. Ther. 19, 35 (2017).

pubmed: 28187781 pmcid: 5303242 doi: 10.1186/s13075-017-1248-6

Erez, N., Truitt, M., Olson, P. & Hanahan, D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell 17, 135–147 (2010). One of the first articles to identify the key role of NF-κB in regulating production of inflammatory factors by CAFs.

pubmed: 20138012 doi: 10.1016/j.ccr.2009.12.041

Koliaraki, V., Pasparakis, M. & Kollias, G. IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer. J. Exp. Med. 212, 2235–2251 (2015).

pubmed: 26621453 pmcid: 4683996 doi: 10.1084/jem.20150542

Sohn, C. et al. Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol. 67, 86–95 (2015).

pubmed: 25199798 pmcid: 4455921 doi: 10.1002/art.38871

Yang, X. et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 76, 4124–4135 (2016).

pubmed: 27216177 doi: 10.1158/0008-5472.CAN-15-2973

Jones, D. S. et al. Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation. Nat. Chem. Biol. 13, 38–45 (2017).

pubmed: 27820799 doi: 10.1038/nchembio.2211

Koliaraki, V. et al. Innate sensing through mesenchymal TLR4/MyD88 signals promotes spontaneous intestinal tumorigenesis. Cell Rep. 26, 536–545.e4 (2019).

pubmed: 30650348 pmcid: 6334226 doi: 10.1016/j.celrep.2018.12.072

Ospelt, C. et al. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 58, 3684–3692 (2008).

pubmed: 19035519 doi: 10.1002/art.24140

Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med. 13, 1324–1332 (2007).

pubmed: 17952090 doi: 10.1038/nm1663

Zhao, S. et al. Selective deletion of MyD88 signaling in αSMA positive cells ameliorates experimental intestinal fibrosis via post-transcriptional regulation. Mucosal Immunol. 13, 665–678 (2020).

pubmed: 32020030 pmcid: 7316631 doi: 10.1038/s41385-020-0259-9

Armaka, M. et al. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205, 331–337 (2008).

pubmed: 18250193 pmcid: 2271010 doi: 10.1084/jem.20070906

Nguyen, H. N. et al. Autocrine loop involving IL-6 family member LIF, LIF receptor, and STAT4 drives sustained fibroblast production of inflammatory mediators. Immunity 46, 220–232 (2017). An article identifying a positive-feedback loop involving NF-κB, LIF and the JAK–STAT pathway, which propagates the inflammatory phenotype of synovial fibroblasts.

pubmed: 28228280 pmcid: 5567864 doi: 10.1016/j.immuni.2017.01.004

Aschenbrenner, D. et al. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut 0, 1–14 (2020).

le Goff, B. et al. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts. Cytokine 68, 101–109 (2014).

pubmed: 24767864 doi: 10.1016/j.cyto.2014.04.001

West, N. R. et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease. Nat. Med. 23, 579–589 (2017).

pubmed: 28368383 pmcid: 5420447 doi: 10.1038/nm.4307

Calvo, F. et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 15, 637–646 (2013).

pubmed: 23708000 doi: 10.1038/ncb2756

Vaughan, M. B., Howard, E. W. & Tomasek, J. J. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. Exp. Cell Res. 257, 180–189 (2000).

pubmed: 10854066 doi: 10.1006/excr.2000.4869

Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518 (2019).

pubmed: 31597160 pmcid: 6876711 doi: 10.1038/s41586-019-1631-3

Wohlfahrt, T. et al. PU.1 controls fibroblast polarization and tissue fibrosis. Nature 566, 344–349 (2019).

pubmed: 30700907 pmcid: 6526281 doi: 10.1038/s41586-019-0896-x

Parsonage, G. et al. A stromal address code defined by fibroblasts. Trends Immunol. 26, 150–156 (2004). A review exploring the importance of stromal adhesion molecules and chemoattractants, termed the ‘stromal address code’, in dictating the identity and phenotype of immune cells in different tissues.

doi: 10.1016/j.it.2004.11.014

Junt, T., Scandella, E. & Ludewig, B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat. Rev. Immunol. 8, 764–775 (2008).

pubmed: 18825130 doi: 10.1038/nri2414

Tikhonova, A. N. et al. The bone marrow microenvironment at single-cell resolution. Nature 569, 222–228 (2019).

pubmed: 30971824 pmcid: 6607432 doi: 10.1038/s41586-019-1104-8

Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, Bil & Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20, 707–718 (2004).

pubmed: 15189736 doi: 10.1016/j.immuni.2004.05.001

Krishnamurty, A. T. & Turley, S. J. Lymph node stromal cells: cartographers of the immune system. Nat. Immunol. 21, 369–380 (2020). A comprehensive review of the mechanisms used by FRCs to regulate immune responses in the lymph node.

pubmed: 32205888 doi: 10.1038/s41590-020-0635-3

Cheng, H. W. et al. Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat. Commun. 10, 1–14 (2019).

doi: 10.1038/s41467-019-09728-3

Perez-Shibayama, C. et al. Type I interferon signaling in fibroblastic reticular cells prevents exhaustive activation of antiviral CD8+ T cells. Sci. Immunol. 5, eabb7066 (2020).

pubmed: 32917792 doi: 10.1126/sciimmunol.abb7066

Pikor, N. B. et al. Integration of Th17- and lymphotoxin-derived signals initiates meningeal-resident stromal cell remodeling to propagate neuroinflammation. Immunity 43, 1160–1173 (2015).

pubmed: 26682987 doi: 10.1016/j.immuni.2015.11.010

Rodda, L. B. et al. Single-cell RNA sequencing of lymph node stromal cells reveals niche-associated heterogeneity. Immunity 48, 1014–1028.e6 (2018).

pubmed: 29752062 pmcid: 5971117 doi: 10.1016/j.immuni.2018.04.006

Link, A. et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8, 1255–1265 (2007).

pubmed: 17893676 doi: 10.1038/ni1513

Luther, S. A. et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169, 424–433 (2002).

pubmed: 12077273 doi: 10.4049/jimmunol.169.1.424

Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G. & Cyster, J. G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl Acad. Sci. USA 97, 12694–12699 (2000).

pubmed: 11070085 pmcid: 18826 doi: 10.1073/pnas.97.23.12694

Bajénoff, M. et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25, 989–1001 (2006).

pubmed: 17112751 pmcid: 2692293 doi: 10.1016/j.immuni.2006.10.011

Wang, X. et al. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J. Exp. Med. 208, 2497–2510 (2011).

pubmed: 22042977 pmcid: 3256970 doi: 10.1084/jem.20111449

Jarjour, M. et al. Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. J. Exp. Med. 211, 1109–1122 (2014).

pubmed: 24863064 pmcid: 4042641 doi: 10.1084/jem.20132409

Wu, Y. et al. IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation. Int. Immunol. 21, 745–756 (2009).

pubmed: 19461124 pmcid: 2686616 doi: 10.1093/intimm/dxp041

Knoblich, K. et al. The human lymph node microenvironment unilaterally regulates T-cell activation and differentiation. PLoS Biol. 16, e2005046 (2018).

pubmed: 30180168 pmcid: 6122729 doi: 10.1371/journal.pbio.2005046

Fletcher, A. L. et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207, 689–697 (2010).

pubmed: 20308362 pmcid: 2856033 doi: 10.1084/jem.20092642

Lee, J. W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat. Immunol. 8, 181–190 (2007).

pubmed: 17195844 doi: 10.1038/ni1427

Pikor, N. B. et al. Remodeling of light and dark zone follicular dendritic cells governs germinal center responses. Nat. Immunol. 21, 649–659 (2020).

pubmed: 32424359 pmcid: 7610477 doi: 10.1038/s41590-020-0672-y

Gregory, J. L. et al. Infection programs sustained lymphoid stromal cell responses and shapes lymph node remodeling upon secondary challenge. Cell Rep. 18, 406–418 (2017).

pubmed: 28076785 doi: 10.1016/j.celrep.2016.12.038

Majumder, S. et al. IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nat. Immunol. 20, 534–545 (2019).

pubmed: 30962593 pmcid: 6519710 doi: 10.1038/s41590-019-0367-4

Tan, K. W. et al. Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation. J. Immunol. 188, 4065–4080 (2012).

pubmed: 22430738 doi: 10.4049/jimmunol.1101854

Roulis, M. et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche. Nature 580, 524–529 (2020).

pubmed: 32322056 pmcid: 7490650 doi: 10.1038/s41586-020-2166-3

Koliaraki, V., Henriques, A., Prados, A. & Kollias, G. Unfolding innate mechanisms in the cancer microenvironment: the emerging role of the mesenchyme. J. Exp. Med. 217, e20190457 (2020).

pubmed: 32044979 pmcid: 7144533 doi: 10.1084/jem.20190457

Jacob, N. et al. Inflammation-independent TL1A-mediated intestinal fibrosis is dependent on the gut microbiome. Mucosal Immunol. 11, 1466–1476 (2018).

pubmed: 29988118 pmcid: 6162160 doi: 10.1038/s41385-018-0055-y

Flannigan, K. L., Nieves, K., Alston, L., Mani, S. & Hirota, S. A. Sensing of a microbial metabolite by fibroblasts through the pregnane X receptor restrains inflammation and fibrosis in mice. J. Can. Assoc. Gastroenterol. 2, 30–31 (2019).

pmcid: 6512679 doi: 10.1093/jcag/gwz006.015

Martin, J. C. et al. Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell 178, 1493–1508.e20 (2019). A landmark article assessing small-bowel resections from patients with ileal Crohn’s disease alongside paired data from peripheral blood using scRNA-seq.

pubmed: 31474370 pmcid: 7060942 doi: 10.1016/j.cell.2019.08.008

Dennis Jr, G. et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res. Ther. 16, R90 (2014).

doi: 10.1186/ar4555

Lewis, M. J. et al. Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep. 28, 2455–2470.e5 (2019).

pubmed: 31461658 pmcid: 6718830 doi: 10.1016/j.celrep.2019.07.091

Buckley, C. D. et al. Persistent induction of the chemokine receptor CXCR4 by TGF-β1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol. 165, 3423–3429 (2000).

pubmed: 10975862 doi: 10.4049/jimmunol.165.6.3423

Bunney, P. E., Zink, A. N., Holm, A. A., Billington, C. J. & Kotz, C. M. Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis. Physiol. Behav. 176, 139–148 (2017).

pubmed: 28363838 pmcid: 5510739 doi: 10.1016/j.physbeh.2017.03.040

Firestein, G. S., Alvaro-Gracia, J. M., Maki, R. & Alvaro-Garcia, J. M. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Immunol. 144, 3347–3353 (1990).

pubmed: 2109776 doi: 10.4049/jimmunol.144.9.3347

Pilling, D. et al. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol. 29, 1041–1050 (1999).

pubmed: 10092109 doi: 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#

Tran, C. N. et al. Molecular interactions between T cells and fibroblast-like synoviocytes role of membrane tumor necrosis factor-on cytokine-activated T cells. Am. J. Pathol. 171, 1588–1598 (2007).

pubmed: 17823284 pmcid: 2043519 doi: 10.2353/ajpath.2007.070004

Müller-Ladner, U. et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149, 1607–1615 (1996).

pubmed: 8909250 pmcid: 1865262

Crowley, T., Buckley, C. D. & Clark, A. R. Stroma: the forgotten cells of innate immune memory. Clin. Exp. Immunol. 193, 24–36 (2018). A review discussing changes in fibroblast properties imprinted by inflammation.

pubmed: 29729109 pmcid: 6038004 doi: 10.1111/cei.13149

Ai, R. et al. DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis. Arthritis Rheumatol. 67, 1978–1980 (2015).

pubmed: 25808728 pmcid: 4485541 doi: 10.1002/art.39123

Firestein, G. S. DNA methylome signature in rheumatoid arthritis. Jpn. J. Clin. Immunol. 35, 367b (2012).

doi: 10.2177/jsci.35.367b

Karouzakis, E. et al. Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis. Sci. Rep. 8, 7370 (2018).

pubmed: 29743579 pmcid: 5943364 doi: 10.1038/s41598-018-24240-2

Whitaker, J. W. et al. An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype. Genome Med. 5, 40 (2013).

pubmed: 23631487 pmcid: 3706831 doi: 10.1186/gm444

Barone, F. et al. Stromal fibroblasts in tertiary lymphoid structures: a novel target in chronic inflammation. Front. Immunol. 7, 1–19 (2016).

doi: 10.3389/fimmu.2016.00477

Buckley, C. D., Barone, F., Nayar, S., Bénézech, C. & Caamaño, J. Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu. Rev. Immunol. 33, 715–745 (2015).

pubmed: 25861980 doi: 10.1146/annurev-immunol-032713-120252

Cañete, J. D. et al. Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis. Arthritis Res. Therapy 17, 173 (2015).

doi: 10.1186/s13075-015-0688-0

Goya, S. et al. Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung. J. Pathol. 200, 82–87 (2003).

pubmed: 12692845 doi: 10.1002/path.1321

Husson, H. et al. Functional effects of TNF and lymphotoxin α1β2 on FDC-like cells. Cell. Immunol. 203, 134–143 (2000).

pubmed: 11006011 doi: 10.1006/cimm.2000.1688

Lee, J. J. et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. Pneumologie 52, 168 (1998).

Luther, S. A., Ansel, K. M. & Cyster, J. G. Overlapping roles of CXCL13, interleukin 7 receptor α, and CCR7 ligands in lymph node development. J. Exp. Med. 197, 1191–1198 (2003).

pubmed: 12732660 pmcid: 2193976 doi: 10.1084/jem.20021294

Nayar, S. et al. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology. Proc. Natl Acad. Sci. USA 116, 13490–13497 (2019).

pubmed: 31213547 pmcid: 6613169 doi: 10.1073/pnas.1905301116

Barone, F. et al. IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs. Proc. Natl Acad. Sci. USA 112, 11024–11029 (2015).

pubmed: 26286991 pmcid: 4568258 doi: 10.1073/pnas.1503315112

Peduto, L. et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J. Immunol. 182, 5789–5799 (2009).

pubmed: 19380827 doi: 10.4049/jimmunol.0803974

Luther, S. A., Lopez, T., Bai, W., Hanahan, D. & Cyster, J. G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12, 471–481 (2000).

pubmed: 10843380 doi: 10.1016/S1074-7613(00)80199-5

Rangel-Moreno, J. et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639–646 (2011).

pubmed: 21666689 pmcid: 3520063 doi: 10.1038/ni.2053

Wu, Q. et al. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193, 1327–1332 (2001).

pubmed: 11390440 pmcid: 2193383 doi: 10.1084/jem.193.11.1327

Link, A. et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am. J. Pathol. 178, 1662–1675 (2011).

pubmed: 21435450 pmcid: 3070229 doi: 10.1016/j.ajpath.2010.12.039

Manzo, A. et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am. J. Pathol. 171, 1549–1562 (2007).

pubmed: 17982129 pmcid: 2043516 doi: 10.2353/ajpath.2007.061275

Bugatti, S. et al. High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology 53, 1886–1895 (2014).

pubmed: 24764267 doi: 10.1093/rheumatology/keu163

Cantaert, T. et al. B Lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J. Immunol. 181, 785–794 (2008).

pubmed: 18566445 doi: 10.4049/jimmunol.181.1.785

Klimiuk, P. A., Goronzy, J. J., Björnsson, J., Beckenbaugh, R. D. & Weyand, C. M. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am. J. Pathol. 151, 1311–1319 (1997).

pubmed: 9358757 pmcid: 1858087

Lanfant-Weybel, K. et al. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy - a pilot study from the VErA cohort. Jt. Bone Spine 79, 574–580 (2012).

doi: 10.1016/j.jbspin.2011.11.006

Thurlings, R. M. et al. Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype. Arthritis Rheum. 58, 1582–1589 (2008).

pubmed: 18512774 doi: 10.1002/art.23505

van de Sande, M. G. H. et al. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time? Ann. Rheum. Dis. 70, 700–703 (2011).

pubmed: 21173012 doi: 10.1136/ard.2010.139287

Risselada, A. P., Looije, M. F., Kruize, A. A., Bijlsma, J. W. J. & van Roon, J. A. G. The role of ectopic germinal centers in the immunopathology of primary Sjögren’s syndrome: a systematic review. Semin. Arthritis Rheum. 42, 368–376 (2013).

pubmed: 22995442 doi: 10.1016/j.semarthrit.2012.07.003

Theander, E. et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann. Rheum. Dis. 70, 1363–1368 (2011).

pubmed: 21715359 doi: 10.1136/ard.2010.144782

Sautès-Fridman, C., Petitprez, F., Calderaro, J. & Fridman, W. H. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer 19, 307–325 (2019).

pubmed: 31092904 doi: 10.1038/s41568-019-0144-6

Cabrita, R. et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561–565 (2020).

pubmed: 31942071 doi: 10.1038/s41586-019-1914-8

Gonzalez, H., Hagerling, C. & Werb, Z. Roles of the immune system in cancer: From tumor initiation t metastatic progression. Genes Dev. 32, 1267–1284 (2018).

pubmed: 30275043 pmcid: 6169832 doi: 10.1101/gad.314617.118

Dieu-Nosjean, M. C. et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J. Clin. Oncol. 26, 4410–4417 (2008).

pubmed: 18802153 doi: 10.1200/JCO.2007.15.0284

Ladányi, A. et al. Density of DC-LAMP

pubmed: 17279413 doi: 10.1007/s00262-007-0286-3

Martinet, L. et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 71, 5678–5687 (2011).

pubmed: 21846823 doi: 10.1158/0008-5472.CAN-11-0431

Goc, J. et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res. 74, 705–715 (2014).

pubmed: 24366885 doi: 10.1158/0008-5472.CAN-13-1342

Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).

pubmed: 22193102 pmcid: 3967235 doi: 10.1038/nature10673

Montfort, A. et al. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin. Cancer Res. 23, 250–262 (2017).

pubmed: 27354470 doi: 10.1158/1078-0432.CCR-16-0081

Germain, C. et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am. J. Respir. Crit. Care Med. 189, 832–844 (2014).

pubmed: 24484236 doi: 10.1164/rccm.201309-1611OC

Nielsen, J. S. et al. CD20+ tumor-infiltrating lymphocytes have an atypical CD27 - memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin. Cancer Res. 18, 3281–3292 (2012).

pubmed: 22553348 doi: 10.1158/1078-0432.CCR-12-0234

Schlößer, H. A. et al. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies. OncoImmunology 8, e1512458 (2019).

pubmed: 30546950 doi: 10.1080/2162402X.2018.1512458

Chen, L., Qiu, X., Wang, X. & He, J. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression. Biochem. Biophys. Res. Commun. 487, 8–14 (2017).

pubmed: 28302482 doi: 10.1016/j.bbrc.2017.03.039

Cohen, N. et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of chitinase 3-like 1. Oncogene 36, 4457–4468 (2017).

pubmed: 28368410 pmcid: 5507301 doi: 10.1038/onc.2017.65

Comito, G. et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene 33, 2423–2431 (2014).

pubmed: 23728338 doi: 10.1038/onc.2013.191

Gunderson, A. J. et al. Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. PLoS ONE 14, e0211117 (2019).

pubmed: 30726287 pmcid: 6364920 doi: 10.1371/journal.pone.0211117

Ksiazkiewicz, M. et al. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts. Immunobiology 215, 737–747 (2010).

pubmed: 20605053 doi: 10.1016/j.imbio.2010.05.019

Pautu, J. L. & Kumar, L. Intratumoral T cells and survival in epithelial ovarian cancer. Natl Med. J. India 16, 150–151 (2003).

pubmed: 12929858

Azimi, F. et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J. Clin. Oncol. 30, 2678–2683 (2012).

pubmed: 22711850 doi: 10.1200/JCO.2011.37.8539

Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).

pubmed: 17008531 doi: 10.1126/science.1129139

Feig, C. et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc. Natl Acad. Sci. USA 110, 20212–20217 (2013).

pubmed: 24277834 pmcid: 3864274 doi: 10.1073/pnas.1320318110

Gorchs, L. et al. Human pancreatic carcinoma-associated fibroblasts promote expression of co-inhibitory markers on CD4+ and CD8+ T-cells. Front. Immunol. 10, 847 (2019).

pubmed: 31068935 pmcid: 6491453 doi: 10.3389/fimmu.2019.00847

Lakins, M. A., Ghorani, E., Munir, H., Martins, C. P. & Shields, J. D. Cancer-associated fibroblasts induce antigen-specific deletion of CD8

pubmed: 29507342 pmcid: 5838096 doi: 10.1038/s41467-018-03347-0

Hsu, Y. L. et al. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis. Oncotarget 7, 27584–27598 (2016).

pubmed: 27050278 pmcid: 5053673 doi: 10.18632/oncotarget.8488

Xiao, Q. et al. Cancer-associated fibroblasts in pancreatic cancer are reprogrammed by tumor-induced alterations in genomic DNA methylation. Cancer Res. 76, 5395–5404 (2016).

pubmed: 27496707 pmcid: 5026619 doi: 10.1158/0008-5472.CAN-15-3264

Vizoso, M. et al. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts. Carcinogenesis 36, 1453–1463 (2015).

pubmed: 26449251 pmcid: 4662832

Albrengues, J. et al. Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat. Commun. 6, 10204 (2015).

pubmed: 26667266 doi: 10.1038/ncomms10204

Direkze, N. C. et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64, 8492–8495 (2004).

pubmed: 15574751 doi: 10.1158/0008-5472.CAN-04-1708

Hosaka, K. et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc. Natl Acad. Sci. USA 113, E5618–E5627 (2016).

pubmed: 27608497 pmcid: 5035870 doi: 10.1073/pnas.1608384113

Ishii, G. et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cell 23, 699–706 (2005).

doi: 10.1634/stemcells.2004-0183

Petersen, O. W. et al. Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am. J. Pathol. 162, 391–402 (2003).

pubmed: 12547698 pmcid: 1851146 doi: 10.1016/S0002-9440(10)63834-5

Quante, M. et al. Bone marrow-derived myofibroblasts contribute to the growth MSC niche and promote tumour growth. Cancer Cell 19, 257–272 (2012).

doi: 10.1016/j.ccr.2011.01.020

Zeisberg, E. M., Potenta, S., Xie, L., Zeisberg, M. & Kalluri, R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 10123–10128 (2007).

pubmed: 17974953 doi: 10.1158/0008-5472.CAN-07-3127

Raz, Y. et al. Bone marrow-derived fibroblasts are a functionally distinct stromal cell population in breast cancer. J. Exp. Med. 215, 3075–3093 (2018).

pubmed: 30470719 pmcid: 6279405 doi: 10.1084/jem.20180818

Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat. Protoc. 15, 1484–1506 (2020). CellPhoneDB performs ligand–receptor analysis on datasets, from which interactions between different cell types can be inferred.

pubmed: 32103204 doi: 10.1038/s41596-020-0292-x

Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159–162 (2020). NicheNet is another computational tool that can predict interactions between cell types, as well as the effects of particular ligands on gene expression in responding cells.

pubmed: 31819264 doi: 10.1038/s41592-019-0667-5

Duperret, E. K. et al. Alteration of the tumor stroma using a consensus DNA vaccine targeting fibroblast activation protein (FAP) synergizes with antitumor vaccine therapy in Mice. Clin. Cancer Res. 24, 1190–1201 (2018).

pubmed: 29269377 doi: 10.1158/1078-0432.CCR-17-2033

Fang, J. et al. A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice. Int. J. Cancer 138, 1013–1023 (2016).

pubmed: 26334777 doi: 10.1002/ijc.29831

Loeffler, M., Krüger, J. A., Niethammer, A. G. & Reisfeld, R. A. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 116, 1955–1962 (2006).

pubmed: 16794736 pmcid: 1481657 doi: 10.1172/JCI26532

Ostermann, E. et al. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin. Cancer Res. 14, 4584–4592 (2008).

pubmed: 18628473 doi: 10.1158/1078-0432.CCR-07-5211

Wang, L. C. S. et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol. Res. 2, 154–166 (2014).

pubmed: 24778279 doi: 10.1158/2326-6066.CIR-13-0027

Roberts, E. W. et al. Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia. J. Exp. Med. 210, 1137–1151 (2013).

pubmed: 23712428 pmcid: 3674708 doi: 10.1084/jem.20122344

Özdemir, B. C. et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell 25, 719–734 (2014).

pubmed: 24856586 pmcid: 4180632 doi: 10.1016/j.ccr.2014.04.005

Calon, A. et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012).

pubmed: 23153532 pmcid: 3512565 doi: 10.1016/j.ccr.2012.08.013

Mariathasan, S. et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544–548 (2018).

pubmed: 29443960 pmcid: 6028240 doi: 10.1038/nature25501

Ohshio, Y. et al. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine. Cancer Sci. 106, 134–142 (2015).

pubmed: 25483888 pmcid: 4399032 doi: 10.1111/cas.12584

Takai, K., Le, A., Weaver, V. M. & Werb, Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget 7, 82889–82901 (2016).

pubmed: 27756881 pmcid: 5341254 doi: 10.18632/oncotarget.12658

Bai, Y. P. et al. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer Sci. 106, 1278–1287 (2015).

pubmed: 26183471 pmcid: 4637995 doi: 10.1111/cas.12745

Sherman, M. H. et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell 159, 80–93 (2014).

pubmed: 25259922 pmcid: 4177038 doi: 10.1016/j.cell.2014.08.007

Katoh, M. FGFR inhibitors: effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review). Int. J. Mol. Med. 38, 3–15 (2016).

pubmed: 27245147 pmcid: 4899036 doi: 10.3892/ijmm.2016.2620

Richeldi, L. et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370, 2071–2082 (2014).

pubmed: 24836310 doi: 10.1056/NEJMoa1402584

Tan, H.-Y. et al. Targeting tumour microenvironment by tyrosine kinase inhibitor. Mol. Cancer 17, 43 (2018).

pubmed: 29455663 pmcid: 5817793 doi: 10.1186/s12943-018-0800-6

Alivernini, S. et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat. Med. 26, 1295–1306 (2020). A key article identifying unique macrophage populations enriched in RA, resolution and flare. These populations are involved in complex crosstalk with joint fibroblasts.

pubmed: 32601335 doi: 10.1038/s41591-020-0939-8

Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6, 583–588 (2000).

pubmed: 10802717 doi: 10.1038/75068

Danese, S. et al. Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II). Gut 68, 40–48 (2019).

pubmed: 29247068 doi: 10.1136/gutjnl-2017-314562

Gout, T., Östör, A. J. K. & Nisar, M. K. Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review. Clin. Rheumatol. 30, 1471–1474 (2011).

pubmed: 21833686 doi: 10.1007/s10067-011-1827-x

Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).

pubmed: 17068223 pmcid: 4410764 doi: 10.1126/science.1135245

Elson, C. O. et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132, 2359–2370 (2007).

pubmed: 17570211 doi: 10.1053/j.gastro.2007.03.104

Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310–1316 (2006).

pubmed: 16670770 pmcid: 1451201 doi: 10.1172/JCI21404

Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo- controlled trial. Gut 61, 1693–1700 (2012).

pubmed: 22595313 doi: 10.1136/gutjnl-2011-301668

Targan, S. R. et al. A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn’s disease. Am. J. Gastroenterol. 111, 1599–1607 (2016).

pubmed: 27481309 doi: 10.1038/ajg.2016.298

Al-Sadi, R. et al. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway. PLoS ONE 9, e85345 (2014).

pubmed: 24662742 pmcid: 3963839 doi: 10.1371/journal.pone.0085345

Lee, J. S. et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43, 727–738 (2015).

pubmed: 26431948 pmcid: 6044435 doi: 10.1016/j.immuni.2015.09.003

Fibroblasts as immune regulators in infection, inflammation and cancer.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Pagination

Subventions

Informations de copyright

Références

Auteurs

Sarah Davidson (S)

Mark Coles (M)

Tom Thomas (T)

George Kollias (G)

Burkhard Ludewig (B)

Shannon Turley (S)

Michael Brenner (M)

Christopher D Buckley (CD)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH